Dexcom (Nasdaq:DXCM) shares ticked up after hours on second-quarter results that topped the consensus forecast.
Shares of DXCM rose 2.3% at $132.35 apiece after the market closed today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.6%.
The San Diego-based continuous glucose monitor (CGM) maker posted profits of $115.9 million. That equals 28¢ per share on sales of $871.3 million for the three months ended June 30, 2023.
Dexcom more than doubled its profits on sales growth of 25.2%.
Get the full story at our sister site, Drug Delivery Business News.